Mateon Therapeutics appointed Giancarlo Mennella, Managing Director at EGAMID LTD, to lead its licensing activity for Trabedersen (OT-101) for COVID-19 globally with emphasis on South America where the treatment for COVID-19 is especially needed. Mr. Giancarlo Mennella is an accomplished executive with extensive international experience in the Pharmaceutical industry and successful track record of achievements in various senior management positions including General Management, Business Development and licensing as well as in International Product Brokering. He is a result- oriented professional with strong negotiational skills developed in an international context.